EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunostimulation Signaling via Toll-like Receptor 2 Activation: A Molecular Mechanism of Lactococcus lactis OTG1204 In Vitro and In Vivo

Hyeon-A Song, Seo-Yun Jang, Min-Ji Park, Seung Wook Kim, Choon Gil Kang, Joo Hyun Lee, Hye-Jin Kim iD, Jiheon Kim iD, Jong Kil Lee, Kyung-Sook Chung, Kyung-Tae Lee iD

Nutrients · 2024

DOI: 10.3390/nu16213629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Hyeon-A Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Lactococcus lactis, Toll-Like Receptor 2, Probiotics, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: OTTOGI Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The immune system’s defense against pathogens involves innate and adaptive responses, crucial in maintaining overall health. Immunosuppressed states render individuals more susceptible to potential diseases, indicating the need for effective strategies to bolster immune functions.

Objectives

Although the immunostimulatory effects of various probiotics have been studied, the specific effects and molecular mechanisms of Lactococcus lactis OTG1204 (OTG1204) remain unknown. In this study, the aim was to investigate the molecular mechanisms of OTG1204 in RAW 264.7 macrophages, the key effector cells of the innate immune system involved in host defense and inflammatory responses. Additionally, in this study, the effects of OTG1204 on cyclophosphamide (CTX)-induced immunosuppression states were investigated, thereby demonstrating its potential as an immune stimulant.

Methods

To assess the macrophage activation ability and underlying mechanisms of OTG1204, RAW 264.7 cells were utilized with transfection, enzyme-linked immunosorbent assay, and quantitative real-time PCR analyses. Furthermore, to evaluate the immunostimulatory effects under immunosuppressed conditions, CTX-induced immunosuppression mice model was employed, and analyses were performed using hematoxylin and eosin staining, flow cytometry, and microbiota examination.

Results

OTG1204 activated RAW 264.7 macrophages, leading to increased production of nitric oxide, prostaglandin E2, and cytokines. This immune activation was mediated through the upregulation of toll-like receptor 2, which subsequently activated the nuclear factor-κB (NF-kB) and mitogen-activated protein kinase (MAPK)/activator protein 1 (AP-1) pathways, thereby stimulating the immune response. In CTX-treated mice, OTG1204 recovered body weight, spleen, and mesenteric lymph node indices, and natural killer cell activity. It re-established populations of innate and adaptive immune cells and activated T cells to secrete cytokines. We also examined the gut barrier integrity and microbiota composition to assess OTG1204’s impact on intestinal health, as these factors play a significant role in immune enhancement. OTG1204 enhanced gut barrier integrity by upregulating mucin 2 and tight junction proteins and modulated the gut microbiota by restoring the Firmicutes/Bacteroidetes balance and reducing the abundance of Actinobacteria and Tenericutes.

Conclusion

These results suggest that OTG1204 may serve as an effective probiotic for immune enhancement and gut health management by targeting the NF-κB and MAPK/AP-1 pathways, with minimal side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactococcus lactisToll-Like Receptor 2ProbioticsSignal TransductionAnimalsMiceRAW 264.7 CellsMacrophagesMacrophage ActivationCyclophosphamideGastrointestinal MicrobiomeNF-kappa BImmunity, InnateCytokines

Stichwörter der Autor:innen

Lactococcus lactis OTG1204cyclophosphamidegut microbiotaimmunemacrophagesprobiotics

Substanzen

Toll-Like Receptor 2Tlr2 protein, mouseCyclophosphamideNF-kappa BCytokines

Autor:innen und Institutionen

  • Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Fundamental Pharmaceutical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Ottogi Research Center, Anyang 14060, Republic of Korea.

ORCID-Profile: Hye-Jin Kim, Jiheon Kim, Kyung-Tae Lee

Förderung

  • OTTOGI Corporation

Zitieren

APA

Song, H. A., Jang, S. Y., Park, M. J., Kim, S. W., Kang, C. G., Lee, J. H., Kim, H. J., Kim, J., Lee, J. K., Chung, K. S., & Lee, K. T. (2024). Immunostimulation Signaling via Toll-like Receptor 2 Activation: A Molecular Mechanism of Lactococcus lactis OTG1204 In Vitro and In Vivo. Nutrients. https://doi.org/10.3390/nu16213629

Vancouver

Song HA, Jang SY, Park MJ, Kim SW, Kang CG, Lee JH, et al. Immunostimulation Signaling via Toll-like Receptor 2 Activation: A Molecular Mechanism of Lactococcus lactis OTG1204 In Vitro and In Vivo. Nutrients. 2024. doi:10.3390/nu16213629

BibTeX
@article{Song2024,
  author = {Song, Hyeon-A and Jang, Seo-Yun and Park, Min-Ji and Kim, Seung Wook and Kang, Choon Gil and Lee, Joo Hyun and Kim, Hye-Jin and Kim, Jiheon and Lee, Jong Kil and Chung, Kyung-Sook and Lee, Kyung-Tae},
  title = {Immunostimulation Signaling via Toll-like Receptor 2 Activation: A Molecular Mechanism of Lactococcus lactis OTG1204 In Vitro and In Vivo},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16213629}
}
Kostenlos starten →